Cargando…

High Prevalence of Sarcopenia in HIV-Infected Individuals

BACKGROUND: Sarcopenia is a geriatric syndrome that leads to a loss of functionality and mortality. METHODS: We assessed the prevalence of sarcopenia in HIV-infected patients attended in our HIV Unit who had at least two DXA scans from 2000 to 2016 (1,720 DXA scans from 860 individuals). Sarcopenia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Echeverría, Patricia, Bonjoch, Anna, Puig, Jordi, Estany, Carla, Ornelas, Arelly, Clotet, Bonaventura, Negredo, Eugenia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6077654/ https://www.ncbi.nlm.nih.gov/pubmed/30112397 http://dx.doi.org/10.1155/2018/5074923

Ejemplares similares

Randomised Study to Assess the Efficacy and Safety of Once-Daily Etravirine-Based Regimen as a Switching Strategy in HIV-Infected Patients Receiving a Protease Inhibitor–Containing Regimen. Etraswitch Study
por: Echeverría, Patricia, et al.
Publicado: (2014)

Prospective Study to Assess Progression of Renal Markers after Interruption of Tenofovir due to Nephrotoxicity
por: Bonjoch, Anna, et al.
Publicado: (2016)

Association between lipid genetic and immunological status in chronically HIV-infected patients
por: Echeverría, Patricia, et al.
Publicado: (2014)

Polymorphisms in LPL, CETP, and HL protect HIV-infected patients from atherogenic dyslipidemia in an allele-dose-dependent manner
por: Echeverría, Patricia, et al.
Publicado: (2014)

Prevalence of Ischemic Heart Disease and Management of Coronary Risk in Daily Clinical Practice: Results from a Mediterranean Cohort of HIV-Infected Patients
por: Echeverría, Patricia, et al.
Publicado: (2014)

Time of Progression to Osteopenia/Osteoporosis in Chronically HIV-Infected Patients: Screening DXA Scan
por: Negredo, Eugenia, et al.
Publicado: (2012)

A randomized pilot trial to evaluate the benefit of the concomitant use of atorvastatin and Raltegravir on immunological markers in protease-inhibitor-treated subjects living with HIV
por: Negredo, Eugènia, et al.
Publicado: (2020)

Impact of protease inhibitors on the evolution of urinary markers: Subanalyses from an observational cross-sectional study
por: Bonjoch, Anna, et al.
Publicado: (2016)

Prevalence, evolution, and related risk factors of kidney disease among Spanish HIV-infected individuals
por: Juega-Mariño, Javier, et al.
Publicado: (2017)

Remote Health Monitoring in the Workplace for Early Detection of COVID-19 Cases during the COVID-19 Pandemic Using a Mobile Health Application: COVIDApp.
por: Echeverría, Patricia, et al.
Publicado: (2021)

Preserved immune functionality and high CMV-specific T-cell responses in HIV-infected individuals with poor CD4(+) T-cell immune recovery
por: Gómez-Mora, Elisabet, et al.
Publicado: (2017)

Antiretroviral Simplification with Darunavir/Ritonavir Monotherapy in Routine Clinical Practice: Safety, Effectiveness, and Impact on Lipid Profile
por: Santos, José R., et al.
Publicado: (2012)

Effectiveness of a Treatment Switch to Nevirapine plus Tenofovir and Emtricitabine (or Lamivudine) in Adults with HIV-1 Suppressed Viremia
por: Llibre, Josep M., et al.
Publicado: (2015)

Increased ex vivo cell death of central memory CD4 T cells in treated HIV infected individuals with unsatisfactory immune recovery
por: Massanella, Marta, et al.
Publicado: (2015)

Elevated humoral response to cytomegalovirus in HIV-infected individuals with poor CD4(+) T-cell immune recovery
por: Gómez-Mora, Elisabet, et al.
Publicado: (2017)

Effectiveness of physically ablative and pharmacological treatments for anal condyloma in HIV-infected men
por: Vela, Sandra, et al.
Publicado: (2018)

Randomized, crossover, double-blind, placebo-controlled trial to assess the lipid lowering effect of co-formulated TDF/FTC
por: Ramón Santos, José, et al.
Publicado: (2014)

Clinical and Emotional Factors Related to Erectile Dysfunction in HIV-Infected Men
por: Fumaz, Carmina R., et al.
Publicado: (2016)

COVIDApp as an Innovative Strategy for the Management and Follow-Up of COVID-19 Cases in Long-Term Care Facilities in Catalonia: Implementation Study
por: Echeverría, Patricia, et al.
Publicado: (2020)

Classification Models for Neurocognitive Impairment in HIV Infection Based on Demographic and Clinical Variables
por: Muñoz-Moreno, Jose A., et al.
Publicado: (2014)

Aging in HIV-Infected Subjects: A New Scenario and a New View
por: Negredo, Eugenia, et al.
Publicado: (2017)

Antiretroviral therapy suppressed participants with low CD4(+) T-cell counts segregate according to opposite immunological phenotypes
por: Pérez-Santiago, Josué, et al.
Publicado: (2016)

Different Plasma Markers of Inflammation Are Influenced by Immune Recovery and cART Composition or Intensification in Treated HIV Infected Individuals
por: Massanella, Marta, et al.
Publicado: (2014)

Gut Microbiota Linked to Sexual Preference and HIV Infection
por: Noguera-Julian, Marc, et al.
Publicado: (2016)

Screening NK-, B- and T-cell phenotype and function in patients suffering from Chronic Fatigue Syndrome
por: Curriu, Marta, et al.
Publicado: (2013)

Effect of Maraviroc Intensification on HIV-1-Specific T Cell Immunity in Recently HIV-1-Infected Individuals
por: Kawana-Tachikawa, Ai, et al.
Publicado: (2014)

Stable HIV-1 integrase diversity during initial HIV-1 RNA Decay suggests complete blockade of plasma HIV-1 replication by effective raltegravir-containing salvage therapy
por: Noguera-Julian, Marc, et al.
Publicado: (2013)

Herb-drug interaction between Echinacea purpurea and darunavir/ritonavir in HIV-infected patients
por: Moltó, J, et al.
Publicado: (2010)

Effects of integrase inhibitor-based antiretroviral therapy on brain outcomes according to time since acquisition of HIV-1 infection
por: Prats, Anna, et al.
Publicado: (2021)

Prevalence of HPV-DNA and E6 mRNA in lung cancer of HIV-infected patients
por: Sirera, Guillem, et al.
Publicado: (2022)

Isocyanides as Acceptor Groups in MHAT Reactions with Unactivated Alkenes
por: Puig, Jordi, et al.
Publicado: (2023)

Anti-MPER antibodies with heterogeneous neutralization capacity are detectable in most untreated HIV-1 infected individuals
por: Molinos-Albert, Luis M, et al.
Publicado: (2014)

Identifying the needs of older people living with HIV (≥ 50 years old) from multiple centres over the world: a descriptive analysis
por: Grosso, Tomás Martín, et al.
Publicado: (2023)

Antibodies and Antibody Derivatives: New Partners in HIV Eradication Strategies
por: Carrillo, Jorge, et al.
Publicado: (2018)

Combined training improves the diagnostic measures of sarcopenia and decreases the inflammation in HIV‐infected individuals
por: Ghayomzadeh, Morteza, et al.
Publicado: (2022)

Expansion of antibody secreting cells and modulation of neutralizing antibody activity in HIV infected individuals undergoing structured treatment interruptions
por: Llano, Anuska, et al.
Publicado: (2013)

Adherence and health beliefs in a psychoeducative intervention in naïve HIV-1-infected men: the PROADH study
por: Fumaz, C, et al.
Publicado: (2012)

Prevalence of sarcopenia and related factors in community-dwelling elderly individuals
por: Simsek, Hatice, et al.
Publicado: (2019)

Prevalence of and factors associated with sarcopenia among elderly individuals with hypertension
por: Xing, Enwang, et al.
Publicado: (2022)

Atlas of the HIV-1 Reservoir in Peripheral CD4 T Cells of Individuals on Successful Antiretroviral Therapy
por: Gálvez, Cristina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_72g66q8us6cc2nioakpendg5lv